Lori J. Pierce
#120,061
Most Influential Person Now
American radiation oncologist
Lori J. Pierce's AcademicInfluence.com Rankings
Lori J. Piercemedical Degrees
Medical
#2284
World Rank
#2697
Historical Rank
#453
USA Rank
Oncology
#191
World Rank
#197
Historical Rank
#21
USA Rank
Download Badge
Medical
Lori J. Pierce's Degrees
- Bachelors Chemistry Kalamazoo College
Why Is Lori J. Pierce Influential?
(Suggest an Edit or Addition)According to Wikipedia, Lori Jo Pierce is an American radiation oncologist and 57th President of the American Society of Clinical Oncology. She is a Full Professor and Vice Provost for Academic and Faculty Affairs at the University of Michigan. Her research focuses on the use of radiotherapy in the multi-modality treatment of breast cancer, with emphasis on intensity modulated radiotherapy in node positive breast cancer, the use of radiosensitizing agents, and the outcomes of women treated with radiation for breast cancer who are carriers of a BRCA1/2 breast cancer susceptibility gene.
Lori J. Pierce's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials (2005) (6940)
- Tamoxifen for early breast cancer: an overview of the randomised trials (1998) (3764)
- Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10 801 women in 17 randomised trials (2011) (2313)
- Ten-year results of a comparison of conservation with mastectomy in the treatment of stage I and II breast cancer. (1995) (870)
- Breast Cancer, Version 3.2020, NCCN Clinical Practice Guidelines in Oncology. (2020) (615)
- Long-term outcomes for neoadjuvant versus adjuvant chemotherapy in early breast cancer: meta-analysis of individual patient data from ten randomised trials (2018) (614)
- Adjuvant bisphosphonate treatment in early breast cancer: meta-analyses of individual patient data from randomised trials (2015) (550)
- Development and validation of a heart atlas to study cardiac exposure to radiation following treatment for breast cancer. (2011) (541)
- Radiation-related heart disease: current knowledge and future prospects. (2010) (524)
- Breast cancer. Clinical practice guidelines in oncology. (2009) (498)
- Estimating the Risks of Breast Cancer Radiotherapy: Evidence From Modern Radiation Doses to the Lungs and Heart and From Previous Randomized Trials. (2017) (473)
- Radiation dose-volume effects in the heart. (2010) (466)
- Breast Cancer, Version 4.2017, NCCN Clinical Practice Guidelines in Oncology. (2018) (426)
- Complications and patient satisfaction following expander/implant breast reconstruction with and without radiotherapy. (2001) (376)
- Regional Nodal Irradiation in Early-Stage Breast Cancer. (2015) (350)
- NCCN Guidelines Insights: Breast Cancer, Version 1.2017. (2017) (344)
- Variability of target and normal structure delineation for breast cancer radiotherapy: an RTOG Multi-Institutional and Multiobserver Study. (2007) (329)
- Ten-year multi-institutional results of breast-conserving surgery and radiotherapy in BRCA1/2-associated stage I/II breast cancer. (2006) (322)
- Invasive breast cancer version 1.2016 (2016) (307)
- Fractionation for whole breast irradiation: an American Society for Radiation Oncology (ASTRO) evidence-based guideline. (2011) (300)
- Changes in surgical management resulting from case review at a breast cancer multidisciplinary tumor board (2006) (281)
- NCCN Guidelines Insights Breast Cancer, Version 1.2016. (2015) (281)
- Clinical cancer advances 2008: major research advances in cancer treatment, prevention, and screening--a report from the American Society of Clinical Oncology. (2009) (277)
- NCIC CTG MA.20: An intergroup trial of regional nodal irradiation in early breast cancer. (2011) (266)
- Effect of radiotherapy after breast-conserving treatment in women with breast cancer and germline BRCA1/2 mutations. (2000) (257)
- Long-term primary results of accelerated partial breast irradiation after breast-conserving surgery for early-stage breast cancer: a randomised, phase 3, equivalence trial (2019) (230)
- Unacceptable cosmesis in a protocol investigating intensity-modulated radiotherapy with active breathing control for accelerated partial-breast irradiation. (2010) (226)
- Statement of the science concerning locoregional treatments after preoperative chemotherapy for breast cancer: a National Cancer Institute conference. (2008) (219)
- Breast cancer, version 3.2013: featured updates to the NCCN guidelines. (2015) (204)
- Increasing the dose intensity of chemotherapy by more frequent administration or sequential scheduling: a patient-level meta-analysis of 37 298 women with early breast cancer in 26 randomised trials (2019) (197)
- Long‐term outcome after breast‐conservation treatment with radiation for mammographically detected ductal carcinoma in situ of the breast (2005) (196)
- Breast Cancer, Version 3.2013 (2013) (193)
- The lncRNA landscape of breast cancer reveals a role for DSCAM-AS1 in breast cancer progression (2016) (190)
- Cancer in the contralateral breast after radiotherapy for breast cancer. (1992) (181)
- Breast cancer version 3.2014. (2014) (180)
- Invasive Breast Cancer Version 1.2016, NCCN Clinical Practice Guidelines in Oncology. (2016) (176)
- Radiotherapy and adjuvant trastuzumab in operable breast cancer: tolerability and adverse event data from the NCCTG Phase III Trial N9831. (2009) (175)
- Local therapy in BRCA1 and BRCA2 mutation carriers with operable breast cancer: comparison of breast conservation and mastectomy (2010) (169)
- Breast cancer version 2.2015: Clinical practice guidelines in oncology (2015) (165)
- The NCCN. Invasive breast cancer: Clinical practice guidelines in oncology™ (2007) (165)
- Postmastectomy radiotherapy of the chest wall: dosimetric comparison of common techniques. (2002) (164)
- Mammographically detected ductal carcinoma in situ of the breast treated with breast-conserving surgery and definitive breast irradiation: long-term outcome and prognostic significance of patient age and margin status. (2001) (159)
- NCCN Guidelines Insights: Breast Cancer, Version 3.2018. (2019) (154)
- Breast Cancer Version 2.2015. (2015) (149)
- Complications After Mastectomy and Immediate Breast Reconstruction for Breast Cancer: A Claims-Based Analysis (2016) (146)
- Clinical and Radiologic Assessments to Predict Breast Cancer Pathologic Complete Response to Neoadjuvant Chemotherapy (2005) (140)
- NCCN Task Force Report: Estrogen Receptor and Progesterone Receptor Testing in Breast Cancer by Immunohistochemistry. (2009) (139)
- Invasive breast cancer. (2011) (133)
- Management of Hereditary Breast Cancer: American Society of Clinical Oncology, American Society for Radiation Oncology, and Society of Surgical Oncology Guideline. (2020) (132)
- Adoption of intensity-modulated radiation therapy for breast cancer in the United States. (2011) (131)
- A cost comparison analysis of partial versus whole-breast irradiation after breast-conserving surgery for early-stage breast cancer. (2005) (127)
- Potential gains for irradiation of chest wall and regional nodes with intensity modulated radiotherapy. (2003) (127)
- Sequencing of tamoxifen and radiotherapy after breast-conserving surgery in early-stage breast cancer. (2005) (123)
- Metastatic breast cancer, version 1.2012: featured updates to the NCCN guidelines. (2012) (120)
- Mastectomy versus conservative surgery and radiation therapy. Psychosocial consequences (1994) (118)
- Development and Validation of a Novel Radiosensitivity Signature in Human Breast Cancer (2015) (117)
- Sentinel node biopsy prior to neoadjuvant chemotherapy. (2003) (114)
- Differences in the Acute Toxic Effects of Breast Radiotherapy by Fractionation Schedule: Comparative Analysis of Physician-Assessed and Patient-Reported Outcomes in a Large Multicenter Cohort. (2015) (113)
- NCCN Guidelines® Insights: Breast Cancer, Version 4.2021. (2021) (111)
- Planning the breast tumor bed boost: changes in the excision cavity volume and surgical scar location after breast-conserving surgery and whole-breast irradiation. (2006) (109)
- Locally advanced breast carcinoma: accuracy of mammography versus clinical examination in the prediction of residual disease after chemotherapy. (1996) (107)
- Breast Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology. (2022) (106)
- Breast conservation and prolonged chemotherapy for locally advanced breast cancer: the University of Michigan experience. (1997) (100)
- Workshop on partial breast irradiation: state of the art and the science, Bethesda, MD, December 8-10, 2002. (2004) (96)
- Definition of the supraclavicular and infraclavicular nodes: implications for three-dimensional CT-based conformal radiation therapy. (2001) (92)
- Evaluation of four techniques using intensity-modulated radiation therapy for comprehensive locoregional irradiation of breast cancer. (2010) (91)
- The effect of systemic therapy on local-regional control in locally advanced breast cancer. (1992) (89)
- The use of radiotherapy after mastectomy: a review of the literature. (2005) (84)
- Maternal Embryonic Leucine Zipper Kinase (MELK) as a Novel Mediator and Biomarker of Radioresistance in Human Breast Cancer (2016) (83)
- Mammographic screening of TRAM flap breast reconstructions for detection of nonpalpable recurrent cancer. (2002) (81)
- Trastuzumab for early-stage, HER2-positive breast cancer: a meta-analysis of 13 864 women in seven randomised trials (2021) (81)
- Rates of myocardial infarction and coronary artery disease and risk factors in patients treated with radiation therapy for early‐stage breast cancer (2007) (80)
- Conservative surgery and radiation therapy in black women with early stage breast cancer. Patterns of failure and analysis of outcome (1992) (77)
- Is there a dose-response relationship for heart disease with low-dose radiation therapy? (2013) (74)
- Microscopic extracapsular extension in the axilla: is this an indication for axillary radiotherapy? (1995) (74)
- Assessment of skin dose for breast chest wall radiotherapy as a function of bolus material (2007) (74)
- Respiratory motion of the heart and positional reproducibility under active breathing control. (2005) (73)
- The conservative management of Paget's disease of the breast with radiotherapy (1997) (68)
- Late Toxicity Is Not Increased in BRCA1/BRCA2 Mutation Carriers Undergoing Breast Radiotherapy in the United Kingdom (2006) (65)
- Postoperative Radiotherapy After Breast-Conserving Surgery for Early-Stage Breast Cancer: A Review. (2016) (63)
- 1998-1999 patterns of care study process survey of national practice patterns using breast-conserving surgery and radiotherapy in the management of stage I-II breast cancer. (2005) (62)
- Salvage treatment for local recurrence after breast‐conserving surgery and radiation as initial treatment for mammographically detected ductal carcinoma in situ of the breast (2001) (61)
- Primary soft tissue sarcomas of the breast: local-regional control with post-operative radiotherapy. (1993) (61)
- Invasive breast cancer. (2007) (60)
- Choosing wisely? Patterns and correlates of the use of hypofractionated whole-breast radiation therapy in the state of Michigan. (2014) (59)
- Cardiac chamber and coronary artery doses associated with postmastectomy radiotherapy techniques to the chest wall and regional nodes. (2004) (58)
- Stroke rates and risk factors in patients treated with radiation therapy for early-stage breast cancer. (2006) (56)
- NCCN Task Force Report: breast cancer in the older woman. (2008) (55)
- Dosimetry around metallic ports in tissue expanders in patients receiving postmastectomy radiation therapy: an ex vivo evaluation. (2004) (53)
- Decline of cosmetic outcomes following accelerated partial breast irradiation using intensity modulated radiation therapy: results of a single-institution prospective clinical trial. (2013) (52)
- Breast Cancer, Version 3.2022 (2022) (52)
- A clinical trial of breast radiation therapy versus breast plus regional radiation therapy in early-stage breast cancer: the MA20 trial. (2003) (51)
- Short-term displacement and reproducibility of the breast and nodal targets under active breathing control. (2007) (50)
- Recent Time Trends and Predictors of Heart Dose From Breast Radiation Therapy in a Large Quality Consortium of Radiation Oncology Practices. (2017) (48)
- Adjuvant radiotherapy (RT) and trastuzumab in stage I-IIA breast cancer: Toxicity data from North Central Cancer Treatment Group Phase III trial N9831. (2006) (47)
- Conservative management of Paget disease of the breast with radiotherapy (2003) (47)
- Clinical aspects of intensity-modulated radiotherapy in the treatment of breast cancer. (2002) (47)
- Clinicogenomic Radiotherapy Classifier Predicting the Need for Intensified Locoregional Treatment After Breast-Conserving Surgery for Early-Stage Breast Cancer (2019) (46)
- A Randomized Comparison of Radiation Therapy Techniques in the Management of Node-Positive Breast Cancer: Primary Outcomes Analysis. (2018) (45)
- Conservative management of Paget disease of the breast with radiotherapy: 10- and 15-year results. (2002) (44)
- Radiotherapy in the treatment of hereditary breast cancer. (2011) (43)
- Abstract GS4-04: Primary results of NSABP B-39/RTOG 0413 (NRG Oncology): A randomized phase III study of conventional whole breast irradiation (WBI) versus partial breast irradiation (PBI) for women with stage 0, I, or II breast cancer (2019) (42)
- Concurrent Veliparib With Chest Wall and Nodal Radiotherapy in Patients With Inflammatory or Locoregionally Recurrent Breast Cancer: The TBCRC 024 Phase I Multicenter Study. (2018) (42)
- Conservative surgery and radiotherapy for early-stage breast cancer using a lung density correction: the University of Michigan experience. (1997) (42)
- Cost-effectiveness of adding an electron-beam boost to tangential radiation therapy in patients with negative margins after conservative surgery for early-stage breast cancer. (2000) (41)
- Androgen receptor as a mediator and biomarker of radioresistance in triple-negative breast cancer (2017) (41)
- Insulin‐like growth factor and epidermal growth factor independence in human mammary carcinoma cells with c‐erbB‐2 gene amplification and progressively elevated levels of tyrosine‐phosphorylated p185erbB‐2 (1996) (39)
- Aromatase inhibitors versus tamoxifen in premenopausal women with oestrogen receptor-positive early-stage breast cancer treated with ovarian suppression: a patient-level meta-analysis of 7030 women from four randomised trials (2022) (39)
- Cost-effectiveness of radiation therapy following conservative surgery for ductal carcinoma in situ of the breast. (2005) (36)
- Late effects of dose fractionation on the mechanical properties of breast skin following post-lumpectomy radiotherapy. (1999) (36)
- Delivering Cancer Care During the COVID-19 Pandemic: Recommendations and Lessons Learned From ASCO Global Webinars (2020) (36)
- Postmastectomy radiotherapy in the management of operable breast cancer (1994) (35)
- TTK inhibition radiosensitizes basal-like breast cancer through impaired homologous recombination. (2020) (35)
- Long‐Term Results of Conservative Surgery and Radiotherapy for Ductal Carcinoma In Situ Using Lung Density Correction: The University of Michigan Experience (2007) (34)
- Accelerated partial breast irradiation: what is dosimetric effect of advanced technology approaches? (2009) (33)
- Treatment guidelines and techniques in delivery of postmastectomy radiotherapy in management of operable breast cancer. (2001) (33)
- NCCN Guidelines® Insights: Breast Cancer, Version 4.2021. (2021) (32)
- Defining the role of post-mastectomy radiotherapy: the new evidence. (1996) (32)
- Acute Chemotherapy–Related Toxicity Is Not Increased in BRCA1 and BRCA2 Mutation Carriers Treated for Breast Cancer in the United Kingdom (2006) (31)
- Recurrent cancer after breast-conserving surgery with radiation therapy for ductal carcinoma in situ: mammographic features, method of detection, and stage of recurrence. (2007) (30)
- Salvage treatment for local or local-regional recurrence after initial breast conservation treatment with radiation for ductal carcinoma in situ. (2005) (30)
- Status of postmastectomy radiotherapy in the United States: a patterns of care study. (2004) (29)
- A dose intensity study of FLAC (5-fluorouracil, leucovorin, doxorubicin, cyclophosphamide) chemotherapy and Escherichia coli-derived granulocyte-macrophage colony-stimulating factor (GM-CSF) in advanced breast cancer patients. (1994) (29)
- Targeted radiosensitization with PARP1 inhibition: optimization of therapy and identification of biomarkers of response in breast cancer (2014) (29)
- PARP1 Inhibition Radiosensitizes Models of Inflammatory Breast Cancer to Ionizing Radiation (2019) (29)
- Radiation Therapy without Endocrine Therapy for Women Age 70 or Above with Low-Risk Early Breast Cancer: A Microsimulation. (2019) (28)
- American Society of Clinical Oncology Strategic Plan for Increasing Racial and Ethnic Diversity in the Oncology Workforce. (2017) (28)
- Is lobular carcinoma in situ as a component of breast carcinoma a risk factor for local failure after breast‐conserving therapy? (2006) (28)
- Postmastectomy radiotherapy: more than locoregional control. (1994) (27)
- ARe we there yet? Understanding androgen receptor signaling in breast cancer (2020) (25)
- Is c-erb B-2 a predictor for recurrent disease in early stage breast cancer? (1994) (23)
- Treatment choices and response rates in African‐American women with breast carcinoma (2003) (21)
- NCIC-CTG MA.20: An intergroup trial of regional nodal irradiation in early breast cancer. (2011) (21)
- Conservative surgery and radiotherapy for stage I/II breast cancer using lung density correction: 10-year and 15-year results. (2005) (21)
- Assessing the benefit of radiation therapy after breast-conserving surgery for ductal carcinoma-in-situ. (2005) (21)
- Ischemic Cardiac Events Following Treatment of the Internal Mammary Nodal Region Using Contemporary Radiation Planning Techniques. (2017) (21)
- Short-term CDK4/6 Inhibition Radiosensitizes Estrogen Receptor–Positive Breast Cancers (2020) (20)
- Randomized Phase III Trial Evaluating Radiation Following Surgical Excision for Good-Risk Ductal Carcinoma In Situ: Long-Term Report From NRG Oncology/RTOG 9804 (2021) (19)
- Seviteronel, a Novel CYP17 Lyase Inhibitor and Androgen Receptor Antagonist, Radiosensitizes AR-Positive Triple Negative Breast Cancer Cells (2020) (18)
- Contralateral breast dose after whole-breast irradiation: an analysis by treatment technique. (2012) (17)
- Radiotherapy for breast cancer in BRCA1/BRCA2 carriers: clinical issues and management dilemmas. (2002) (17)
- Quantifying dose to the reconstructed breast: can we adequately treat? (2011) (17)
- Increasing Racial and Ethnic Diversity in Cancer Clinical Trials: An American Society of Clinical Oncology and Association of Community Cancer Centers Joint Research Statement. (2022) (17)
- Neoadjuvant Docetaxel and Capecitabine and the Use of Thymidine Phosphorylase as a Predictive Biomarker in Breast Cancer (2007) (17)
- Postmastectomy radiation therapy for patients with locally advanced breast cancer. (2009) (17)
- Molecular Signatures of Radiation Response in Breast Cancer: Towards Personalized Decision-Making in Radiation Treatment (2017) (17)
- Body Mass Index Predicts the Incidence of Radiation Pneumonitis in Breast Cancer Patients (2005) (16)
- Utility of cranial boost in addition to total body irradiation in the treatment of high risk acute lymphoblastic leukemia. (2004) (16)
- Contemporary Statewide Practice Pattern Assessment of the Palliative Treatment of Bone Metastasis. (2018) (15)
- Development of a model web-based system to support a statewide quality consortium in radiation oncology. (2017) (15)
- Identifying Patients Whose Symptoms Are Underrecognized During Treatment With Breast Radiotherapy. (2022) (15)
- Wide Variation in the Diffusion of a New Technology: Practice-Based Trends in Intensity-Modulated Radiation Therapy (IMRT) Use in the State of Michigan, With Implications for IMRT Use Nationally. (2015) (15)
- The use of mammography in breast preservation in locally advanced breast cancer. (1996) (14)
- Current controversies in breast cancer management. (1999) (14)
- Breast Cancer (2023) (14)
- Radiotherapy using a water bath in the treatment of Bowen's disease of the digit. (2008) (14)
- Cost-effectiveness analysis of endocrine therapy alone versus partial-breast irradiation alone versus combined treatment for low-risk hormone-positive early-stage breast cancer in women aged 70 years or older (2020) (13)
- Radiation Treatments May Contribute to the Development of Cardiac Dysfunction in Breast Cancer Patients Treated with Chemotherapy and Trastuzumab (2008) (13)
- Individualized, patient-centered application of consensus guidelines to improve the quality of breast cancer care. (2014) (13)
- ARe we there yet? Understanding androgen receptor signaling in breast cancer (2020) (12)
- A Phase I Dose Escalation Trial of Gemcitabine with Radiotherapy for Breast Cancer in the Treatment of Unresectable Chest Wall Recurrences (2004) (12)
- Breast Cancer Research and Treatment 2001 Reviewers (2004) (12)
- Dosimetric predictors for acute esophagitis during radiation therapy for lung cancer: Results of a large statewide observational study. (2017) (12)
- A signature that may be predictive of early vs. late recurrence after radiation treatment (RT) for breast cancer that may inform the biology of early, aggressive recurrences. (2020) (12)
- Mechanical properties of the shoulder and pectoralis major in breast cancer patients undergoing breast-conserving surgery with axillary surgery and radiotherapy (2019) (11)
- Decreased Lung Perfusion After Breast/Chest Wall Irradiation: Quantitative Results From a Prospective Clinical Trial. (2017) (11)
- Radiation therapy to the internal mammary nodal region in breast cancer: the debate continues. (2013) (11)
- An academic health center cost analysis of screening mammography (2004) (10)
- Toward Improving Patients' Experiences of Acute Toxicity From Breast Radiotherapy: Insights From the Analysis of Patient-Reported Outcomes in a Large Multicenter Cohort. (2020) (10)
- Predictors of Pneumonitis after Conventionally Fractionated Radiotherapy for Locally Advanced Lung Cancer. (2021) (10)
- Comprehensive Transcriptomic Profiling Identifies Breast Cancer Patients Who May Be Spared Adjuvant Systemic Therapy (2019) (10)
- Evaluation of multiple breathing states using a multiple instance geometry approximation (MIGA) in inverse-planned optimization for locoregional breast treatment. (2008) (9)
- The Role of Facility Variation on Racial Disparities in Use of Hypofractionated Whole Breast Radiotherapy. (2019) (9)
- Breast cancer: noninvasive and special situations. (2010) (9)
- Is an axillary boost necessary in node positive stage II disease in the presence of microscopic extracapsular extension (1993) (9)
- Cardiac Dose in Locally Advanced Lung Cancer: Results from a Statewide Consortium. (2019) (9)
- Abstract S5-08: Late side-effects of breast cancer radiotherapy: Second cancer incidence and non-breast-cancer mortality among 40,000 women in 75 trials (2016) (8)
- Adverse Cosmesis in a Protocol Investigating IMRT with Active Breathing Control for Accelerated Partial Breast Irradiation (APBI) (2008) (8)
- Addressing Equity, Diversity, and Inclusion of Black Physicians in the Oncology Workforce. (2021) (8)
- Development and Validation of a Novel Platform-Independent Metastasis Signature in Human Breast Cancer (2015) (8)
- RB expression confers sensitivity to CDK4/6 inhibitor–mediated radiosensitization across breast cancer subtypes (2021) (7)
- Patient-reported outcomes (PROs) in NRG oncology/NSABP B-39/RTOG 0413: A randomized phase III study of conventional whole breast irradiation (WBI) versus partial breast irradiation (PBI) in stage 0, I, or II breast cancer. (2019) (7)
- The potential gains for chestwall and regional nodal irradiation using intensity modulated radiation therapy (IMRT) (2001) (7)
- Patterns of recurrence by sequence of chemotherapy and radiotherapy in early stage breast cancer (2003) (7)
- Recommendations for single faction radiation therapy and stereotactic body radiation therapy in palliative treatment of bone metastases: A statewide practice patterns survey. (2019) (7)
- Postmastectomy radiotherapy: future directions. (1999) (7)
- COMMENTARY Workshop on Partial Breast Irradiation: State of the Art and the Science, Bethesda, MD, (2004) (6)
- Comparative Effectiveness Analysis of 3D-Conformal Radiotherapy versus Intensity Modulated Radiotherapy (IMRT) in a Prospective Multicenter Cohort of Breast Cancer Patients. (2021) (6)
- TBCRC 024 Initial Results: A Multicenter Phase 1 Study of Veliparib Administered Concurrently With Chest Wall and Nodal Radiation Therapy in Patients With Inflammatory or Locoregionally Recurrent Breast Cancer (2015) (6)
- Genetic Factors in the Locoregional Management of Breast Cancer. (2020) (6)
- Development of an Illustrated Scale for Acute Radiation Dermatitis in Breast Cancer Patients. (2020) (6)
- Stromal cells in phyllodes tumors of the breast are enriched for EZH2 and stem cell marker expression (2016) (6)
- Attention to diet, exercise, and weight in oncology care: Results of an American Society of Clinical Oncology national patient survey (2022) (6)
- Outcomes following breast conservation versus mastectomy in BRCA1/2 carriers with early-stage breast cancer (2008) (6)
- Oral PresentationVariability of Target and Normal Structure Delineation for Breast-Cancer Radiotherapy: A RTOG Multi-Institutional and Multi-Observer Study (2007) (5)
- Minimizing cardiotoxicity following breast radiotherapy: treatment planning is the key. (2001) (5)
- Breast Cancer: New Radiation Treatment Options (2004) (5)
- Comparison of practice patterns and treatment techniques for regional nodal irradiation with breast conservation vs. postmastectomy in stage I-II breast cancer (2004) (5)
- Web based pathology assessment in RTOG 98-04 (2014) (5)
- Modulating the Radiation Response for Improved Outcomes in Breast Cancer. (2021) (5)
- Development of a new photonumeric scale for acute radiation dermatitis in patients with breast cancer. (2015) (5)
- Immune Infiltrate in the Primary Tumor Predicts Effect of Adjuvant Radiotherapy in Breast Cancer; Results from the Randomized SweBCG91RT Trial (2020) (5)
- Local Therapy in BRCA1/2 Carriers with Operable Breast Cancer: Comparison of Breast Conservation and Mastectomy. (2009) (4)
- Cardiac MRI and blood biomarkers for evaluation of radiation-induced cardiotoxicity in breast cancer patients: results of a phase II clinical trial. (2021) (4)
- Androgen Receptor (AR) As a Mediator and Biomarker of Radioresistance in Triple-Negative Breast Cancer. (2016) (4)
- Radiosensitization of androgen receptor (AR)-positive triple-negative breast cancer (TNBC) cells using seviteronel (SEVI), a selective CYP17 lyase and AR inhibitor. (2017) (4)
- Strategies to Advance Equity in Cancer Clinical Trials. (2022) (4)
- ASTRO Radiation Therapy Summary of the ASCO-ASTRO-SSO Guideline on Management of Hereditary Breast Cancer. (2020) (4)
- Patient Perceptions on a Non-Blinded Randomized Trial of Radiotherapy Technologies: A Novel Survey Study Exploring Therapeutic Misconception. (2020) (3)
- Association Between Physician and Patient Reported Symptoms in Patients Treated with Definitive Radiotherapy for Locally Advanced Lung Cancer in a Statewide Consortium. (2021) (3)
- Discovery and validation of a genomic signature to identify women with early-stage invasive breast cancer who may safely omit adjuvant radiotherapy after breast-conserving surgery. (2021) (3)
- Radiotherapy is an efficacious option for patients with Bowens disease (2004) (3)
- Active Smoking Is Not Associated with Increased Radiation-Induced Toxicity in Locally Advanced Lung Cancer Patients (2018) (3)
- Abstract PD6-1: The long noncoding RNA M41 promotes aggressiveness and tamoxifen resistance in ER-positive breast cancers (2015) (3)
- Is lobular carcinoma in situ as a component of breast carcinoma a risk factor for local failure after breast-conserving therapy? Presented in part at the 46th American Society for Therapeutic Radiology and Oncology Meeting, Atlanta, Georgia, October 3–7, 2004. (2006) (3)
- Development of a Photonumeric Scale for Acute Radiation Dermatitis in Breast Cancer Patients (2014) (3)
- 1998-1999 patterns of care survey (PCS) update of national practice patterns using breast-conserving surgery (BCS) and radiotherapy (RT) in the management of stage I/II breast cancer (2002) (3)
- Regional Nodal Radiotherapy in Early-Stage Breast Cancer: Where Are We in 2016? (2016) (3)
- In pursuit of equity in cancer care: Moving beyond the Affordable Care Act (2022) (3)
- 2021 Presidential Address: Equity: Every Patient. Every Day. Everywhere. (2021) (2)
- Contemporary Practice Patterns for Intact and Post-Operative Prostate Cancer: Results from a Statewide Collaborative (2019) (2)
- Estrogen receptor inhibition mediates radiosensitization of ER-positive breast cancer models (2022) (2)
- Disease Control After Hypofractionation Versus Conventional Fractionation for Triple Negative Breast Cancer: Comparative Effectiveness in a Large Observational Cohort. (2021) (2)
- PARP-1 inhibitors and radiotherapy sensitivity: future prospects for therapy? (2014) (2)
- A Time to Dig Deeper and Take Meaningful Action. (2020) (2)
- Evaluation of 3 Techniques for Intensity Modulated Radiation to the Breast and Regional Nodes (2009) (2)
- ASCO's Commitment to Addressing Equity, Diversity, and Inclusion of Black Cancer Patients and Survivors. (2021) (2)
- Uptake of Adjuvant Durvalumab After Definitive Concurrent Chemoradiotherapy for Stage III Nonsmall-cell Lung Cancer (2022) (2)
- Abstract P6-06-05: RadiotypeDx: Identification and validation of a radiation sensitivity signature in human breast cancer (2013) (2)
- Cardiac substructure (CS) and coronary artery (CA) doses associated with post-mastectomy radiotherapy (pmrt) techniques to the chest wall (cw) and regional nodes (2002) (2)
- Radiation Therapy Oncology Group. Research Plan 2002-2006. Breast Cancer Working Group. (2001) (2)
- In Response to Dr. Wolmark and Colleagues (2010) (2)
- Managing motion in conventionally fractionated lung cancer radiation therapy: Collaborative quality improvement from a statewide consortium of academic and community practices. (2017) (2)
- 151 Complications and patient satisfaction following breast implant reconstruction with and without radiotherapy (1999) (2)
- Evaluation of Dose Accuracy in the Near-Surface Region for Whole Breast Irradiation Techniques in a Multi-Institutional Consortium. (2022) (2)
- Body mass index (BMI) predicts the incidence of radiation pneumonits (RP) in node-positive breast cancer (2003) (2)
- Inflammatory breast cancer (2014) (2)
- 1091: Partial Breast Irradiation (PBI) Using IMRT Compared With 3D Conformal PBI and Whole Breast Radiotherapy for Early Stage Breast Cancer: The Difference Is in the Normal Tissue (2006) (2)
- Development and Validation of a Genomic Profile for the Omission of Local Adjuvant Radiation in Breast Cancer (2023) (2)
- Adjuvant therapy of breast cancer. Introduction. (1999) (2)
- Salvage treatment for local recurrence after breast-conserving surgery followed by radiation as initial treatment for mammographically-detected ductal carcinoma in situ of the breast (2004) (2)
- Abstract P5-15-02: Evaluating the cost of endocrine therapy vs. radiation therapy alone for low risk hormone positive early stage breast cancer in elderly patients (2019) (2)
- Accelerated whole breast radiotherapy with a concomitant boost using a cone IMRT (cIMRT) technique (2003) (2)
- QRRO 2007 Practice Survey Documents Dramatic Technical Changes in How Radiotherapy for Operable Breast Cancer is Delivered (2010) (2)
- Is Breast Irradiation Routinely Necessary Following Conservation Therapy of Breast Cancer? (1995) (2)
- No Dose Response Relationship for Heart Disease at Low Doses (2011) (1)
- Reduction of dose to the coronary arteries using IMRT for locoregional post-mastectomy irradiation (2001) (1)
- Utilization and Toxicity of Breast Boost Radiation Therapy Following Hypofractionated Whole Breast Irradiation: Comparative Analysis of a Large, Statewide Multicenter Cohort (2018) (1)
- NCCN Breast Cancer Version 3 . 2014 Clinical Practice Guidelines in Oncology (2014) (1)
- Abstract P4-02-12: Validation of Profile for the Omission of Local Adjuvant Radiotherapy (POLAR) in early-stage invasive breast cancer patients of the Scottish Conservation Trial (2023) (1)
- Comprehensive transcriptomic profiling to identify breast cancer patients that may be spared adjuvant systemic therapy. (2018) (1)
- Post-mastectomy radiotherapy: Current status and future directions (1998) (1)
- 113 The use of radiotherapy in the conservative management of pager's disease (1996) (1)
- Availability of data for screening, offering, and consenting patients to cancer clinical trials: Report from an ASCO-ACCC collaboration. (2022) (1)
- Variation in the use of intensity-modulated radiation therapy (IMRT) in the state of Michigan: 2005-2010. (2012) (1)
- Assessing feasibility and utility of an implicit bias training program for addressing disparities in cancer clinical trial participation. (2022) (1)
- The position and reproducibility of the internal mammary nodes under active breathing control (2004) (1)
- 185 : Evaluation of Multiple Instance Geometry Approximation (MIGA) in Inverse-Planned Optimization for Loco-Regional Breast Treatment (2006) (1)
- Breast conservation in locally advanced breast cancer: lessons to be learned. (1996) (1)
- Identification and Validation of a Radiation Sensitivity Signature in Human Breast Cancer (2013) (1)
- Abstract P6-13-05: Androgen receptor (AR): A novel target and mechanism for radiosensitization and treatment in triple-negative breast cancers (TNBC) (2016) (1)
- Changes in pectoralis major stiffness and thickness following radiotherapy for breast cancer: a 12-month follow-up case series. (2022) (1)
- A phase I dose escalation trial of concurrent gemcitabine with standard irradiation for unresectable chest wall recurrences after mastectomy (2002) (1)
- Postmastectomy radiotherapy--a topic for the nineties. (1999) (1)
- 7N Local therapy options in BRCA1/2 carriers with operable breast cancer: the importance of adjuvant chemotherapy (2010) (1)
- Abstract P5-13-02: Impact of Adjuvant Trastuzumab on Local Regional Recurrence: Data from the NCCTG N9831 Study (2010) (1)
- Bcl-xL Inhibition Radiosensitizes PIK3CA/PTEN Wild-type Triple-negative Breast Cancers with Low Mcl-1 Expression (2022) (1)
- The Michigan Radiation Oncology Quality Consortium: A Novel Initiative to Improve the Quality of Radiation Oncology Care. (2022) (1)
- Cardiac MRI for Evaluation of Radiation-Induced Cardiotoxicity in Breast Cancer Patients: A Phase II Clinical Trial (2019) (1)
- The status of post mastectomy radiation (PMR) in the United States: a patterns of care study (PCS) (2002) (1)
- Cardiac Magnetic Resonance Imaging and Blood Biomarkers for Evaluation of Radiation-Induced Cardiotoxicity in Patients With Breast Cancer: Results of a Phase 2 Clinical Trial (2021) (1)
- Abstract GS3-07: Identifying patients whose symptoms are under-recognized during breast radiotherapy: Comparison of patient and physician reports of toxicity in a multicenter cohort (2021) (1)
- Impact of race and socioeconomic status on breast cancer outcomes within the AJCC staging system. (2021) (1)
- An Assessment of the Feasibility and Utility of an ACCC-ASCO Implicit Bias Training Program to Enhance Racial and Ethnic Diversity in Cancer Clinical Trials (2023) (1)
- Association between Adverse Events and Quality of Life in Patients Treated with Radiotherapy for Locally Advanced Non-Small Cell Lung Cancer (2019) (1)
- Mediators of Racial Disparities in Heart Dose among Whole Breast Radiotherapy Patients. (2022) (1)
- Abstract 3924: PARP inhibition as a radiosensitizing strategy to improve locoregional control in inflammatory breast cancer (2019) (1)
- Attention to diet, exercise, and weight in the oncology clinic: Results of a national patient survey. (2021) (1)
- Collaborative Quality Initiative in the Treatment of Breast and Lung Cancer: An Important Step Toward High Quality Cost-Effective Care (2013) (1)
- Genomic Predictors for Radiation Sensitivity and Toxicity in Breast Cancer—from Promise to Reality (2020) (1)
- Androgen and oestrogen receptor co-expression determines the efficacy of hormone receptor-mediated radiosensitisation in breast cancer (2022) (0)
- Factors Associated with Patient-Reported and Physician-Assessed Acute Toxicity after Hypofractionated Breast Radiotherapy, a Report from a Large Multi-Center Cohort Study (2019) (0)
- Radiosensitization of Estrogen Receptor Positive Breast Cancers with Short-Term CDK4/6 Inhibition (2020) (0)
- Changing Practice Patterns in the Radiation Treatment Delivery for Locally Advanced Lung Cancer: Results from a Statewide Consortium (2019) (0)
- Time Trends and Predictors of Heart Dose From Breast Radiation Therapy in a Large Consortium of Community and Academic Practices (2016) (0)
- Long-Term Results of Conservative Surgery and Radiotherapy for Ductal Carcinoma In Situ Using Lung Density Correction (2005) (0)
- Abstract GS4-03: Validation of Profile for the Omission of Local Adjuvant Radiotherapy (POLAR) in a meta-analysis of three randomized controlled trials of breast conserving surgery +/- radiotherapy (2023) (0)
- Quality Improvement in a Statewide Collaborative Radiation Oncology Quality Consortium. (2021) (0)
- Abstract 3218: Maternal embryonic leucine zipper kinase (MELK) confers radioresistance in triple-negative breast cancers (TNBC) through a nonhomologous end joining (NHEJ)-mediated pathway (2018) (0)
- Nailing the Clavicular Head: Assuring Adequate Coverage of the Medial/Inferior Aspect of the Supraclavicular Space in Patients Receiving Regional Nodal Radiation Therapy for Breast Cancer. (2022) (0)
- Abstract 6270: A radiosensitizer screen identifies a novel role for MDM2 inhibition in the radiosensitization of ER+ breast cancers in a p53 dependent manner (2020) (0)
- Prevalence and Impact of Co-morbidities on Treatment of Breast Cancer (2011) (0)
- Abstract PO-028: RB loss mitigates CDK4/6 inhibitor-mediated radiosensitization of estrogen receptor positive (ER+) breast cancers (2021) (0)
- Predictive Factors for Acute Skin Toxicity during Radiotherapy for Breast Cancer (2011) (0)
- Pectoralis muscle dosimetry and post-treatment rehabilitation utilization for early-stage breast cancer patients (2023) (0)
- Use of Chemotherapy in Patients Receiving Hypofractionated Whole-Breast Irradiation: An Analysis within a State-Wide Quality Consortium (2019) (0)
- A Phantom Evaluation of Contralateral Breast Dose for Whole Breast Irradiation Techniques (2009) (0)
- A Subtype-Independent Signature Predictive of Early Versus Late Recurrence After Radiation Treatment for Breast Cancer That May Inform the Biology of Early, Aggressive Recurrences (2017) (0)
- SU‐E‐T‐245: A Physics Database for a Multi‐Institutional Quality Consortium (2013) (0)
- 127 Prospective Screening of Patients with Breast Cancer for Mild and Moderate Lymphedema: Analysis of Natural History and Prognostic Factors (2011) (0)
- Long-term results for women with mammographically detected ductal carcinoma in-situ of the breast treated with breast-conserving surgery and definitive breast irradiation (2003) (0)
- A signature predictive of early versus late recurrence after radiation (RT) for breast cancer that may inform the biology of early, aggressive recurrences. (2019) (0)
- Abstract 1952: CDK4/6 inhibition radiosensitizes RB1 wild type triple negative breast cancers through impaired homologous recombination (2021) (0)
- In Reply to Ling and Beriwal. (2022) (0)
- Knowledge Based Quality Assurance and Improvement in Locally Advanced Lung Cancer Radiation Therapy in a Statewide Consortium of Academic and Community Practice Centers (2018) (0)
- Intratreatment Changes in RAD51 Foci Formation Predict Radiosensitization by PARP1 Inhibition in Breast Cancer Cell Lines (2012) (0)
- Evaluation of Deep Inspiration Breath Hold (DIBH) and Inverse-Planned Optimization Techniques for Loco-Regional Breast Treatment (2005) (0)
- Publisher Correction: Estrogen receptor inhibition mediates radiosensitization of ER-positive breast cancer models (2022) (0)
- Abstract 5839: Androgen receptor (AR): A novel target for radiosensitization in triple-negative breast cancers (TNBC) (2017) (0)
- Abstract S4-05: Interrogating the landscape of long noncoding RNAs in breast cancer to identify predictors of tamoxifen resistance (2016) (0)
- Abstract P2-08-01: Validation of a 16-gene genomic signature to identify early-stage invasive breast cancer patients who may omit radiotherapy (2022) (0)
- Maternal Embryonic Leucine Zipper Kinase (MELK): A Novel Target for Radiosensitization That is Independently Prognostic in Triple-Negative Breast Cancers (2014) (0)
- Impact of Intensity Modulated Radiation Therapy on Acute Toxicity in Locally Advanced Lung Cancer: Results of a Large Statewide Multi-center Cohort (2018) (0)
- Author reply (0)
- Androgen receptor as a mediator and biomarker of radioresistance in triple-negative breast cancer (2017) (0)
- Integrating Tumor-Intrinsic and Immunologic Factors to Identify Immunogenic Breast Cancers from a Low-Risk Cohort: Results from the Randomized SweBCG91RT Trial (2023) (0)
- Changes in Left Ventricular Function after Radiation Therapy and Trastuzumab: Analysis of North Central Cancer Treatment Group Phase III Trial N9831 (2009) (0)
- Increasing Racial and Ethnic Equity, Diversity, and Inclusion in Cancer Treatment Trials: Evaluation of an ASCO-Association of Community Cancer Centers Site Self-Assessment (2023) (0)
- Comparative Effectiveness Analysis of 3DCRT versus Intensity Modulated Radiation Therapy in a Prospective Multicenter Cohort of Breast Cancer Patients (2016) (0)
- Racial Differences in Treatments and Toxicity in Patients With Non–Small-Cell Lung Cancer Treated With Thoracic Radiation Therapy (2022) (0)
- Abstract 215: MDM2 inhibition as a non-hormone dependent radiosensitizing strategy in p53 wild-type breast cancer models (2022) (0)
- Evaluation of an Adaptive Diffusion Smoothing Technique to Improve Delivery Efficiency in Accelerated Partial Breast IMRT (2007) (0)
- Abstract P1-10-02: A signature predictive of early vs. late recurrence after radiation treatment (RT) for breast cancer that may inform the biology of early, aggressive recurrences (2017) (0)
- Abstract P1-15-01: Association between ischemic cardiac events and targeting of the internal mammary nodal region with adjuvant radiation for breast cancer (2015) (0)
- Abstract of ASTRO scientific papers to be presentedThe effect of systemic therapy upon local-regional control in locally adbanced breast cancer (1991) (0)
- Abstract 737: Estrogen receptor inhibition with tamoxifen mediates radiosensitization of ER+ breast cancer models (2021) (0)
- The impact of chemotherapy on toxicity and cosmetic outcome in patients receiving whole breast irradiation: an analysis within a state-wide quality consortium. (2022) (0)
- Predictors of Heart Dose From Lung Radiation Therapy in a Large Consortium of Community and Academic Practices (2016) (0)
- Heterogeneity in the Treatment of Bone Metastases: A Contemporary Statewide Practice Pattern Analysis (2018) (0)
- PHASE III TRIAL OF OBSERVATION +/- TAMOXIFEN VS. RT +/- TAMOXIFEN FOR GOOD RISK DUCT CARCINOMA IN-SITU (DCIS) OF THE FEMALE BREAST (2010) (0)
- 190 : Rates of Myocardial Infarction, Coronary Artery Disease, and Risk Factors in Breast Cancer Patients Treated With Radiation (2006) (0)
- Abstract 6271: Hormone receptor inhibition as a strategy for radiosensitization of breast cancer (2020) (0)
- Predictors of Pneumonitis after Lung Cancer Radiotherapy (2020) (0)
- Practice Pattern Treatment Recommendations for the Treatment of Bone Metastases: A Statewide Survey (2019) (0)
- Abstract PD6-6: Identifying patients at higher risk of toxicity after breast radiotherapy: Analysis of patient-reported outcomes in the Michigan Radiation Oncology Quality Consortium cohort (2020) (0)
- Increasing use of Hypofractionated Whole Breast Irradiation: An Analysis of Practice Patterns within a State-Wide Quality Consortium (2018) (0)
- Facility and Individual-Level Factors Contribute to Racial Disparities in Heart Dose Among Breast Radiotherapy Patients (2019) (0)
- Inhibition of Estrogen Receptor Signaling as a Strategy for Radiosensitization of ER+ Breast Cancers. (2021) (0)
- Impact of Comorbidities on Acute Toxicity in Patients Receiving Radiation Therapy for Locally Advanced Lung Cancer (2018) (0)
- Collection and utilization of oncology big data. (2017) (0)
- E17. Modern radiotherapy planning in the treatment of breast cancer (2010) (0)
- CDK4/6 Inhibition and Radiation as a Treatment Strategy to Improve Local Disease Control in Breast Cancers With Poor Prognoses. (2021) (0)
- Abstract 1386: The role of MDM2 inhibition in the radiosensitization of ER+ breast cancers (2021) (0)
- Abstract 3307: Multiomics analysis to uncover the mechanism of radiosensitization of AR-positive triple negative breast cancers with AR inhibition (2022) (0)
- Abstract P1-09-05: Radiosensitization of androgen receptor (AR)-positive triple-negative breast cancer (TNBC) cells using seviteronel (INO-464), a selective CYP17 lyase and AR inhibitor (2018) (0)
- Non-invasive follow-up of the viscoelasticity of the breast skin following radiation therapy (1998) (0)
- Abstract LB-010: Maternal embryonic leucine zipper kinase (MELK): A novel target for radiosensitization that is independently prognostic in triple-negative breast cancers (2016) (0)
- Abstract P4-02-04: Endocrine therapy treatment radiosensitizes estrogen receptor-positive breast cancers (2022) (0)
- Management of brain metastases from breast carcinoma: Review (1993) (0)
- Abstract P5-12-01: A novel gene expression signature prognostic for both locoregional and distant failure and predictive for adjuvant radiotherapy (2019) (0)
- Abstract 216: Expression of DNA damage response proteins modifies the efficacy of CDK4/6 inhibitor-mediated radiosensitization in breast cancer models (2022) (0)
- Racial Differences in Toxicity in Non-Small Cell Lung Cancer Patients Treated with Thoracic Radiotherapy (2020) (0)
- Postmastectomy Radiation Therapy (2010) (0)
- Statewide rates of adjuvant checkpoint inhibitor use after definitive chemoradiation for stage III non-small cell lung cancer. (2021) (0)
- Decreased Lung Perfusion Following Breast/Chest Wall Irradiation: Preliminary Results of a Prospective Clinical Trial (2014) (0)
- Inhibition of TTK As a Novel Radiosensitization Target in Triple-Negative Breast Cancer That Acts through Impaired Homologous Recombination Repair Efficiency (2019) (0)
- The value of performance metrics in a large statewide consortium: using planning target volumes towards improvements in breast planning. (2018) (0)
- Estrogen receptor inhibition mediates radiosensitization of ER-positive breast cancer models (2022) (0)
- Abstract P6-03-08: Androgen receptor (AR): A novel target for radiosensitization and treatment in triple-negative breast cancers (TNBC) (2015) (0)
- Gene Expression Changes Predict Acute and Late Toxicity to Combined PARP1 Inhibition and Radiation (RT) in High Risk Breast Cancer Patients- Results of the Biomarker Analysis of TBCRC 024 (2018) (0)
- Identification and Validation of a Metastasis Signature in Human Breast Cancer (2014) (0)
- Accelerated partial-breast irradiation: A promising technique under investigation (2007) (0)
- Getting to the heart of the matter. (2014) (0)
- Updates in combined approaches of radiotherapy and immune checkpoint inhibitors for the treatment of breast cancer (2022) (0)
- The Arthur/Morris/Vicini article reviewed (2004) (0)
- Is an axillary dissection indicated in micro-invasive carcinoma of the breast? (1996) (0)
- Comparison of seven commonly used comprehensive radiotherapy treatment techniques for the chestwall and regional nodes using DVH analyses and NTCP predictors for pneumonitis and ischemic heart disease (2000) (0)
- Association Between Ischemic Cardiac Events and Treatment of the Internal Mammary Nodal Region Using Contemporary RT Planning (2015) (0)
- Impact of Cardiac Sparing Techniques on Cardiac Doses for Left Breast Cancer Patients: A Multicenter Analysis (2015) (0)
- Abstract 2539: Discovery of degradation pathway for maternal embryonic leucine zipper kinase (MELK): Implications for breast cancer therapy (2019) (0)
- Personalisation of Radiotherapy for Breast Cancer (2016) (0)
- Abstract P6-04-04: Maternal embryonic leucine zipper kinase (MELK) is a novel radiosensitizing and therapeutic target and is independently prognostic in triple-negative breast cancer (2013) (0)
- Dosimetric Variables Predicting for Acute Esophagitis During Definitive Radiation Therapy for Locally Advanced Non-Small Cell Lung Cancer—Results of a Large Prospective Observational Study (2016) (0)
- Identification of altered growth phenotypes in human breast cancer cells using cell culture methods that support growth of normal and neoplastic mammary epithelial cells (1993) (0)
- The Effect of Radiotherapy Upon Primary Human Mammary Epithelial Cells which Harbor a Breast Cancer Susceptibility Gene. (1997) (0)
- Trends in Close Margin Status and Radiation Therapy Boost in Early Stage Breast Cancer Treated with Breast Conserving Therapy (2020) (0)
- Management update and future directions in the treatment of locally advanced breast cancer (1997) (0)
- Abstract P1-12-18: Mechanical properties of the shoulder and pectoralis major in women undergoing breast conserving therapy with axillary dissection and regional nodal radiotherapy versus sentinel node biopsy and radiotherapy to the breast alone (2019) (0)
- Validation and Extension of a Radiation Sensitivity Signature in Human Breast Cancer: Toward Personalized Risk Stratification (2016) (0)
- Local Treatment Issues in Women with Hereditary Breast Cancer (2007) (0)
- Reply to N. Magné et al (2009) (0)
- Erratum: Late effects of dose fractionation on the mechanical properties of breast skin following post-lumpectomy radiotherapy (International Journal of Radiation Oncology Biology Physics (2000) 46 (975-981)) (2000) (0)
- Abstract PD4-07: Contemporary practice patterns for the use of regional nodal irradiation during post-lumpectomy radiotherapy for patients with N0/N1 breast cancer (2021) (0)
- Response to "local control for locally advanced breast cancer: many opinions, few facts" (1992) (0)
- LCIS as a component of breast cancer: Is it a risk factor for local failure (2004) (0)
- Are We Missing Acute Toxicities Associated with Hypofractionated Breast Irradiation? A Report from a Large Multi-Center Cohort Study (2019) (0)
- Contemporary Practice Patterns for Radiotherapy of Bone Metastases: Preliminary Analysis of Prospective Data from a Statewide Consortium Focusing on Extended Fractionation (2019) (0)
- Mechanical properties of the shoulder and pectoralis major in breast cancer patients undergoing breast-conserving surgery with axillary surgery and radiotherapy (2019) (0)
- Invasive Breast CancerPractice Guidelines in Oncology (2011) (0)
- Abstract P1-15-12: Development of a photonumeric scale for acute radiation dermatitis in breast cancer patients (2015) (0)
- Introduction. Local management of early-stage breast cancer. (2011) (0)
- Publisher Correction: Estrogen receptor inhibition mediates radiosensitization of ER-positive breast cancer models (2022) (0)
- Planning the breast boost: Influence of volumetric changes in the biopsy cavity and surgical scar location following whole breast irradiation (2004) (0)
- Abstract 2823: Targeting monopolar spindle kinase I (TTK) as a radiosensitizing strategy in syngeneic murine models of triple negative breast cancer (TNBC) and its implications on the tumor immune microenvironment (2023) (0)
- Radiation-induced increases in PARP1 activity to predict for long-term radiosensitization by PARP1 inhibition in preclinical breast cancer models. (2013) (0)
- Androgen and oestrogen receptor co-expression determines the efficacy of hormone receptor-mediated radiosensitisation in breast cancer (2022) (0)
- Cost-Effectiveness of Endocrine Therapy Alone versus Partial Breast Irradiation Alone versus Combined Treatment for Women Age ≥70 With Low-Risk Hormone-Positive Early Stage Breast Cancer (2020) (0)
This paper list is powered by the following services:
Other Resources About Lori J. Pierce
What Schools Are Affiliated With Lori J. Pierce?
Lori J. Pierce is affiliated with the following schools:
